Search results
Lonza is a global company that supports healthcare customers on the path to commercialization. It offers technological insight, world-class manufacturing, scientific expertise, process excellence and innovation for pharmaceutical, biotech and nutrition products.
- Careers
Find your job opportunity at Lonza and become part of our...
- About Us
Lonza is one of the world’s largest healthcare manufacturing...
- Locations
We at Lonza take care of our customers and their global,...
- Job Search
These activities range from fake Lonza job adverts being...
- Biologics
Small Biotechs Need: The Right CDMO Tuning the Myeloid...
- Small Molecules
Whether you’re at early or late-stage development, discover...
- Cell & Gene
Access our end-to-end cell & gene therapy services...
- Capsules & Health Ingredients
1970. We introduced the most popular two-piece hard gelatin...
- Careers
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
Lonza is a leading provider of integrated healthcare solutions for pharmaceutical, biotech and nutrition companies. It operates across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients.
1 day ago · Find your job opportunity at Lonza and become part of our global teams. Submit your application now and get one step closer to making a meaningful... Learn more
Lonza is a global company that supports healthcare customers on the path to commercialization. It offers services and products in pharmaceutical ingredients, bioscience, biopharmaceuticals, nutrition, cell therapy, gene therapy and capsules.
Lonza Bioscience provides tools for developing and testing therapeutics, from basic research to final product release. Explore their offerings in discovery tools, bioprocessing media, endotoxin and pyrogen testing, and informatics.
1 day ago · Furthermore, Lonza welcomed its new Chairman of the Board of Directors, Jean-Marc Huët, and announced the appointment of its new CEO Wolfgang Wienand, who joined Lonza on 1 July. Looking to H2 2024, group sales are expected to be higher than H1, reflecting the timing of batch releases and the ramp-up of new facilities in Biologics and Small ...